Company intelligence / Profile preview

o2h ventures Human Health Enterprise Investment Scheme fund

Cambridge, United Kingdom

Ownership: Private
Development stage: Other

Overview

o2h Ventures is a UK-based venture capital firm managing SEIS and EIS funds, specializing in early-stage (seed and pre-seed) investments in biotech companies. Their focus areas include novel drug discovery, AI/ML technologies, and digital therapeutics, with an emphasis on university spinouts and high-unmet-need areas. The current fund is actively open, closing January 31, 2025, with a £10m target and a minimum £10k subscription. As an investor, it does not have a clinical pipeline or stages, but its portfolio includes successful companies like Monument Therapeutics and Exonate.

Industry: Investors

Beyond the preview

Go deeper on o2h ventures Human Health Enterprise Investment Scheme fund.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on o2h ventures Human Health Enterprise Investment Scheme fund.

Explore the full profile